Overview

To Evaluate the Food Effect and the Absorption Profile of Ibuprofen Controlled-Release Tablets 600 mg in Comparison to the Reference Standard Ibuprofen Tablets in Normal Healthy Volunteers

Status:
Terminated

Trial end date:
2020-12-31

Target enrollment:

Participant gender:

Summary

To evaluate the food effect of Ibuprofen CR Tablets 600 mg (IBUCR), and its bioavailability comparison versus 3 doses of the reference arms including Advil® Ibuprofen Tablets 200 mg (IBUAdv) and Motrin® IB Ibuprofen Tablets 200 mg (IBUMot) in normal healthy volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Overseas Pharmaceuticals, Ltd.

Treatments:

Ibuprofen